The PRECIS-2 tool seems not to be useful to discriminate the degree of pragmatism of medicine masked trials from that of open-label trials

R Dal-Ré - European Journal of Clinical Pharmacology, 2021 - Springer
Purpose To assess, with all available trial information, whether the assessment of the
PRECIS-2 nine domains could provide a clear distinction between medicine masked …
被引用次数：10 相关文章

The PRECIS-2 tool seems not to be useful to discriminate the degree of pragmatism of medicine masked trials from that of open-label trials

R Dal-Ré - European journal of clinical pharmacology, 2021 - pubmed.ncbi.nlm.nih.gov
Purpose To assess, with all available trial information, whether the assessment of the
PRECIS-2 nine domains could provide a clear distinction between medicine masked …

The PRECIS-2 tool seems not to be useful to discriminate the degree of pragmatism of medicine masked trials from that of open-label trials.

R Dal-Ré - European Journal of Clinical Pharmacology, 2021 - search.ebscohost.com
Purpose: To assess, with all available trial information, whether the assessment of the
PRECIS-2 nine domains could provide a clear distinction between medicine masked …

The PRECIS-2 tool seems not to be useful to discriminate the degree of pragmatism of medicine masked trials from that of open-label trials.

R Dal-Ré - European Journal of Clinical Pharmacology, 2020 - europepmc.org
Purpose To assess, with all available trial information, whether the assessment of the
PRECIS-2 nine domains could provide a clear distinction between medicine masked …

The PRECIS-2 tool seems not to be useful to discriminate the degree of pragmatism of medicine masked trials from that of open-label trials

R Dal-Ré - European Journal of Clinical Pharmacology, 2021 - search.proquest.com
Purpose To assess, with all available trial information, whether the assessment of the
PRECIS-2 nine domains could provide a clear distinction between medicine masked …